CoChat

Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System

Open access
Daniele, Giuseppe, Iozzo, Patricia, Molina-Carrion, Marjorie, Lancaster, Jack, Ciociaro, Demetrio, Cersosimo, Eugenio, Tripathy, Devjit, Triplitt, Curtis, Fox, Peter, Musi, Nicolas, DeFronzo, Ralph, Gastaldelli, Amalia · 2015 · Diabetes
Cited by 62

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Glucagon-like peptide 1 receptors (GLP-1Rs) have been found in the brain, but whether GLP-1R agonists (GLP-1RAs) influence brain glucose metabolism is currently unknown. The study aim was to evaluate the effects of a single injection of the GLP-1RA exenatide on cerebral and peripheral glucose metabolism in response to a glucose load. In 15 male subjects with HbA1c of 5.7 ± 0.1%, fasting glucose of 114 ± 3 mg/dL, and 2-h glucose of 177 ± 11 mg/dL, exenatide (5 μg) or placebo was injected in double-blind, randomized fashion subcutaneously 30 min before an oral glucose tolerance test (OGTT). The cerebral glucose metabolic rate (CMRglu) was measured by positron emission tomography after an injection of [18F]2-fluoro-2-deoxy-d-glucose before the OGTT, and the rate of glucose absorption (RaO) and disposal was assessed using stable isotope tracers. Exenatide reduced RaO0–60 min (4.6 ± 1.4 vs. 13.1 ± 1.7 μmol/min ⋅ kg) and decreased the rise in mean glucose0–60 min (107 ± 6 vs. 138 ± 8 mg/dL) and insulin0–60 min (17.3 ± 3.1 vs. 24.7 ± 3.8 mU/L). Exenatide increased CMRglu in areas of the brain related to glucose homeostasis, appetite, and food reward, despite lower plasma insulin concentrations, but reduced glucose uptake in the hypothalamus. Decreased RaO0–60 min after exenatide was inversely correlated to CMRglu. In conclusion, these results demonstrate, for the first time in man, a major effect of a GLP-1RA on regulation of brain glucose metabolism in the absorptive state.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db14-1718

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 12

  1. Alvarez, 2005, The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem, J Neurochem, 92, 798, 10.1111/j.1471-4159.2004.02914.x · DOI · Paper page
  2. Schlögl, 2013, Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity, Diabetes Care, 36, 1933, 10.2337/dc12-1925 · DOI · Paper page
  3. Lerche, 2008, Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans, Diabetes, 57, 325, 10.2337/db07-1162 · DOI · Paper page
  4. Gejl, 2012, Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia, J Cereb Blood Flow Metab, 32, 2146, 10.1038/jcbfm.2012.118 · DOI · Paper page
  5. Sisley, 2014, Neuronal GLP1R mediates liraglutide’s anorectic but not glucose-lowering effect, J Clin Invest, 124, 2456, 10.1172/JCI72434 · DOI · Paper page
  6. Matsuda, 1999, Altered hypothalamic function in response to glucose ingestion in obese humans, Diabetes, 48, 1801, 10.2337/diabetes.48.9.1801 · DOI · Paper page
  7. Navarro, 1996, Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake, J Neurochem, 67, 1982, 10.1046/j.1471-4159.1996.67051982.x · DOI · Paper page
  8. Yang, 2004, Metabolic pathways that mediate inhibition of hypothalamic neurons by glucose, Diabetes, 53, 67, 10.2337/diabetes.53.1.67 · DOI
  9. Hussain, 2015, Glucokinase activity in the arcuate nucleus regulates glucose intake, J Clin Invest, 10.1172/JCI77172 · DOI
  10. Banks, 2012, Insulin in the brain: there and back again, Pharmacol Ther, 136, 82, 10.1016/j.pharmthera.2012.07.006 · DOI · Paper page
  11. Hasselbalch, 1999, No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans, Diabetes, 48, 1915, 10.2337/diabetes.48.10.1915 · DOI · Paper page
  12. Bingham, 2002, The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study, Diabetes, 51, 3384, 10.2337/diabetes.51.12.3384 · DOI · Paper page

Cited by

See all 62

Metadata

Authors
Daniele, G., Iozzo, P., Molina-Carrion, M., Lancaster, J., Ciociaro, D., Cersosimo, E., Tripathy, D., Triplitt, C., Fox, P., Musi, N., DeFronzo, R., & Gastaldelli, A.
Venue
Diabetes
Published
2015-06-26
Volume
64
Issue
10
Pages
3406-3412
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W1848685510
Cited by
62
References
8
FWCI
5.32
Type
journal article
Language
en
Open access
green
Funders
  • Amylin Pharmaceuticals, Bristol-Myers Squibb, and AstraZeneca
  • Consiglio Nazionale delle Ricerche (CNR Ageing project)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.